Patents by Inventor Simone Rost

Simone Rost has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240228799
    Abstract: The present invention relates to a compound as a reactive diluent for resin compositions as well as a resin composition comprising the same for coating an article and a resin obtained by curing said resin composition.
    Type: Application
    Filed: May 9, 2022
    Publication date: July 11, 2024
    Inventors: Keiza Fernandes, Sascha Tödter-König, Simon Rost
  • Patent number: 10501656
    Abstract: The present invention relates to a solvent-free wire enamel composition containing extrudable, polyesterimide-containing binders, prepared from polyols, polycarboxylic acids, imide-forming components, and structural elements which are crosslinkable after extrusion.
    Type: Grant
    Filed: August 6, 2012
    Date of Patent: December 10, 2019
    Assignee: ELANTAS GmbH
    Inventors: Ronnie Halfar, Sascha Toedter-Koenig, Klaus-W. Lienert, Simon Rost, Stefan Hartkopp, Hans-Ulrich Moritz
  • Publication number: 20170240867
    Abstract: The invention relates to a novel polypeptide vitamin K epoxide recycling polypeptide (VKORC1) as a target for coumarin and its derivatives. The invention further provides methods for identifying coumarin derivatives, and also claims VKORC1 polypeptides and VKORC1 nucleic acids containing a sequence abnormality associated with a VKORC1 associated deficiency such as warfarin resistance, wherein the VKORC1 polypeptides and VKORC1 nucleic acids can be used for diagnosing these deficiencies. Moreover, the invention relates to methods for identifying coumarin derivatives usable in pest control of rodents.
    Type: Application
    Filed: June 22, 2015
    Publication date: August 24, 2017
    Applicants: Baxalta GmbH, Baxalta Incorporated
    Inventors: Johannes OLDENBURG, Clemens R. MUELLER-REIBLE, Andreas FREGIN, Simone ROST, Tim-Matthias STROM
  • Patent number: 9012697
    Abstract: A process is proposed for preparing hydroxyaromatics by heterogeneous catalytic reaction of hydroxyaromatics with C1-C4-alkanols in a microreactor (10), comprising the steps of: a) introducing the hydroxyaromatic and at least one compound selected from the group consisting of C1-C4-alkanols as reactants into at least one inlet orifice (22) of the microreactor (10) comprising at least one microreactor unit (18), b) passing the reactants through at least one microreactor unit (18) of the microreactor (10), said unit comprising a multitude of microchannels (28), said microchannels (28) having a lateral extent of less than 1 mm, and a heterogeneous catalyst being incorporated in the microchannels (28) for conversion of the reactants, c) passing the hydroxyaromatics prepared out through at least one outlet orifice (24) of the microreactor (10).
    Type: Grant
    Filed: March 7, 2012
    Date of Patent: April 21, 2015
    Assignee: Elantas GmbH
    Inventors: Oliver Bleifuβ, Simon Rost, Klaus-Wilhelm Lienert, Hans-Ulrich Moritz
  • Publication number: 20140205758
    Abstract: The present invention relates to a solvent-free wire enamel composition containing extrudable, polyesterimide-containing binders, prepared from polyols, polycarboxylic acids, imide-forming components, and structural elements which are crosslinkable after extrusion.
    Type: Application
    Filed: August 6, 2012
    Publication date: July 24, 2014
    Applicant: ELANTAS GMBH
    Inventors: Ronnie Halfar, Sascha Toedter-Koenig, Klaus-W. Lienert, Simon Rost, Stefan Hartkopp, Hans-Ulrich Moritz
  • Publication number: 20120238783
    Abstract: A process is proposed for preparing hydroxyaromatics by heterogeneous catalytic reaction of hydroxyaromatics with C1-C4-alkanols in a microreactor (10), comprising the steps of: a) introducing the hydroxyaromatic and at least one compound selected from the group consisting of C1-C4-alkanols as reactants into at least one inlet orifice (22) of the microreactor (10) comprising at least one microreactor unit (18), b) passing the reactants through at least one microreactor unit (18) of the microreactor (10), said unit comprising a multitude of microchannels (28), said microchannels (28) having a lateral extent of less than 1 mm, and a heterogeneous catalyst being incorporated in the microchannels (28) for conversion of the reactants, c) passing the hydroxyaromatics prepared out through at least one outlet orifice (24) of the microreactor (10).
    Type: Application
    Filed: March 7, 2012
    Publication date: September 20, 2012
    Applicant: ELANTAS GmbH
    Inventors: Oliver BLEIFUSS, Simon ROST, Klaus-Wilhelm LIENERT, Hans-Ulrich MORITZ
  • Publication number: 20110154520
    Abstract: The invention relates to a novel polypeptide vitamin K epoxide recycling polypeptide (VKORC1) as a target for coumarin and its derivatives. The invention further provides methods for identifying coumarin derivatives, and also claims VKORC1 polypeptides and VKORC1 nucleic acids containing a sequence abnormality associated with a VKORC1 associated deficiency such as warfarin resistance, wherein the VKORC1 polypeptides and VKORC1 nucleic acids can be used for diagnosing these deficiencies. Moreover, the invention relates to methods for identifying coumarin derivatives usable in pest control of rodents.
    Type: Application
    Filed: November 10, 2010
    Publication date: June 23, 2011
    Applicants: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE S.A.
    Inventors: Johannes Oldenburg, Clemens R. Mueller-Reible, Andreas Fregin, Simone Rost, Tim-Matthias Strom
  • Patent number: 7939250
    Abstract: The invention relates to a novel polypeptide vitamin K epoxide recycling polypeptide (VKORC1) as a target for coumarin and its derivatives. The invention further provides methods for identifying coumarin derivatives, and also claims VKORC1 polypeptides and VKORC1 nucleic acids containing a sequence abnormality associated with a VKORC1 associated deficiency such as warfarin resistance, wherein the VKORC1 polypeptides and VKORC1 nucleic acids can be used for diagnosing these deficiencies. Moreover, the invention relates to methods for identifying coumarin derivatives usable in pest control of rodents.
    Type: Grant
    Filed: October 14, 2004
    Date of Patent: May 10, 2011
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Johannes Oldenburg, Clemens R. Müller-Reible, Andreas Fregin, Simone Rost, Tim-Matthias Strom
  • Publication number: 20090094708
    Abstract: The invention relates to a novel polypeptide vitamin K epoxide recycling polypeptide (VKORC1) as a target for coumarin and its derivatives. The invention further provides methods for identifying coumarin derivatives, and also claims VKORC1 polypeptides and VKORC1 nucleic acids containing a sequence abnormality associated with a VKORC1 associated deficiency such as warfarin resistance, wherein the VKORC1 polypeptides and VKORC1 nucleic acids can be used for diagnosing these deficiencies. Moreover, the invention relates to methods for identifying coumarin derivatives usable in pest control of rodents.
    Type: Application
    Filed: September 5, 2008
    Publication date: April 9, 2009
    Applicants: Baxter International Inc., Baxter Heathcare Corporation
    Inventors: Johannes Oldenburg, Clemens R. Muller-Reible, Andreas Fregin, Simone Rost, Tim-Matthias Strom
  • Publication number: 20050271644
    Abstract: The invention relates to a novel polypeptide vitamin K epoxide recycling polypeptide (VKORC1) as a target for coumarin and its derivatives. The invention further provides methods for identifying coumarin derivatives, and also claims VKORC1 polypeptides and VKORC1 nucleic acids containing a sequence abnormality associated with a VKORC1 associated deficiency such as warfarin resistance, wherein the VKORC1 polypeptides and VKORC1 nucleic acids can be used for diagnosing these deficiencies. Moreover, the invention relates to methods for identifying coumarin derivatives usable in pest control of rodents.
    Type: Application
    Filed: October 14, 2004
    Publication date: December 8, 2005
    Inventors: Johannes Oldenburg, Clemens Muller-Reible, Andreas Fregin, Simone Rost, Tim-Matthias Strom